A carregar...
Ready or not, here it comes: Direct-to-consumer pharmacogenomic testing and its implications for community pharmacists
OBJECTIVE: To explore the implications of direct-to-consumer pharmacogenomic testing for community pharmacy practice. SUMMARY: In October 2018, the U.S. Food and Drug Administration provided approval for direct-to-consumer genetic testing company, 23andMe® (Mountain View, CA), to return select pharm...
Na minha lista:
| Publicado no: | J Am Pharm Assoc (2003) |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7229642/ https://ncbi.nlm.nih.gov/pubmed/31327749 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.japh.2019.06.008 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|